Clin2
NCT07352917Possibly a fitRecruiting

Methotrexate for severe vulvar lichen sclerosus

Vulvar Lichen Sclerosus

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
12 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have lichen sclerosus on your vulva, perineum, or anal area, confirmed by a skin biopsy.
  • Your symptoms have not improved after using a strong corticosteroid cream for at least 3 months.
  • You have significant discomfort, with a score over 24 on a quality-of-life questionnaire.
  • Your blood tests (including liver, kidney, blood cell counts) are normal, and you are not infected with HIV or hepatitis B/C.
  • If you can become pregnant, you have a negative pregnancy test and agree to use effective birth control during the study.
  • You must not plan to become pregnant, must avoid heavy alcohol use, and must be able to attend study visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06662942Recruiting· Phase 1
Testing StrataMGT for vulvar lichen sclerosus symptoms

This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.

Washington D.C., District of Columbia
NCT07363733Recruiting
Comparing radiofrequency vs steroid cream for vulvar lichen sclerosus

This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.

Moscow
NCT07240389Not yet recruiting
Comparing three treatments for vulvar lichen sclerosus

This study compares three different treatments for vulvar lichen sclerosus (a skin condition that can cause itching and pain in the vulvar area): a steroid ointment, a calcineurin inhibitor ointment, and platelet-rich plasma (PRP) therapy. It aims to see which treatment works best to relieve symptoms.

Krakow, Małopolska
NCT06965244Not yet recruiting· Phase 3
Lenalidomide versus methotrexate for stubborn lupus skin disease

This study tests whether the drug lenalidomide works better than methotrexate for people with lupus that mainly affects the skin and is hard to treat. Both drugs are taken by mouth and have been used for other conditions, but this trial compares them directly to see which helps clear the skin rash more effectively.

NCT07704775Not yet recruiting· Phase 2
Nemolizumab for genital lichen sclerosus

This study tests a new injectable medication called nemolizumab to see if it can reduce itching in women with lichen sclerosus affecting the genital area. If you have severe itching that hasn't been fully controlled by steroid creams, this might be an option to explore.

Dallas, Texas
NCT06739551Not yet recruiting· Phase 2
Treatment options for widespread lichen planus

This study compares two medicines, methotrexate and acitretin, to see which one works better for widespread lichen planus, a skin condition that causes itchy, flat bumps. If you join, you will receive one of these treatments to help manage your symptoms.

Rahim Yar Khan, Punjab Province

Hear when a new Vulvar Lichen Sclerosus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.